A patient advocate with overactive bladder talks about how the condition affected her ability to work and the importance of getting treatment. Darlene C. worked as a nurse for nearly three decades.

The JAVELIN Bladder 100 trial established avelumab (Bavencio) as a standard switch maintenance therapy, according to Grivas.

The National Institute for Health and Care Excellence (NICE) has recommended the combination of enfortumab vedotin (Padcev, Astellas) with pembrolizumab (Keytruda, MSD) as a first-line option for ...

Sept 10 (Reuters) - The U.S. Food and Drug Administration has approved Johnson & Johnson's (JNJ.N), opens new tab drug delivery system for a type of bladder cancer, offering a potential surgery-free ...

Sanders aims to destigmatize incontinence by openly discussing his experience and incorporating the product into his image. The ad campaign follows Sanders' surgery where his bladder was removed and ...